← Back to All Stocks

SCYNEXIS, Inc. (SCYX) Analysis

Generated on: 2025-07-26 20:27:11 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$0.71
Predicted Price
$0.84
Expected Return
12.49%
Confidence Score
0.83
RSI (14)
53.85
MACD
-0.02
Volume
61,700
Float Shares
34,664,441
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

SCYX

SCYNEXIS, Inc.
12.49%
Price: $0.71
Confidence: 0.83
News
Low Float
Last updated: 2025-07-26 20:27:10

Technical Analysis

RSI: 53.85
MACD: -0.02
Technical Analysis Graph

Risk Analysis

Volatility
75.05%
Max Drawdown
-68.31%
Beta
1.0
Risk Score
77.3

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold
Insider Monkey - 2025-05-29 04:31
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold, initiated over concerns of beta-lactam contamination at the original manufacturing facility, was removed once new drug batches were produced at a separate location. With trial sites now […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.